The Delhi Drugs Control Department seized insulin stocks worth over Rs 20 lakh from wholesale drug firms for allegedly violating storage and regulatory norms.
The Maharashtra Food and Drug Administration (FDA) conducted three separate operations in Pune and Kolhapur, seizing illegal medicines worth over Rs 24 lakh. Actions included seizing allopathic medicines from an unlicensed firm and prescription drugs with improper promotional packaging, with the FDA vowing strict action against violators.
An illegal factory in Kotdwar, Uttarakhand, allegedly involved in producing fake medicines, has been sealed following a joint operation by the Uttarakhand STF and other departments.
The Delhi government's Drugs Control Department dismantled an illegal medicine sale operation in Shahdara, seizing a significant quantity of drugs and expired items.
The Union Health Ministry has amended drug rules, making it mandatory to have a doctor's prescription for the sale of all syrups, including cough syrups. This move aims to enhance regulatory oversight and patient safety following concerns over drug quality and contamination-linked deaths.
Delhi Police have arrested four individuals involved in an interstate racket manufacturing and distributing counterfeit prescription drugs, uncovering an illegal processing unit in Delhi.
The Uttarakhand Food Safety and Drug Administration (FDA) has stated that a Dehradun-based factory, allegedly involved in the production of the banned synthetic drug Captagon, is not registered in its official records. This follows reports of illegal Captagon production at the 'Green Herbal' factory in Sahaspur.
The Jammu and Kashmir government has issued an order regulating courier companies, parcel services, and logistics operators in Jammu district to prevent the transport of contraband substances.
A sessions court in Mumbai has quashed notices issued against two directors of Amazon Seller Services Private Limited for the alleged illegal online sale of abortion pills, citing that Amazon acts as a platform and not the seller.
A new law is being proposed to grant statutory powers to the Central Drugs Standard Control Organisation to regulate the manufacture, distribution, and sale of drugs, medical devices, and cosmetics.
'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.
The Indian Medical Association (IMA) has defended a doctor arrested in connection with cough syrup deaths in Madhya Pradesh, attributing the incident to failures in the drugs regulatory system.
Following the death of 22 children due to consumption of contaminated cough syrups in Madhya Pradesh three months ago, the Union health ministry has proposed amendments in the country's drug rules to ensure a tougher criterion for their over-the-counter (OTC) sales in India.
Police have arrested a doctor for alleged negligence and registered a case against the manufacturer of a 'toxic' cough syrup after the death of 14 children in Chhindwara due to suspected renal failure, officials said on Sunday.
Though some ingredients such as mild odours or silicones might not be actually harmful, others such as sulphates, parabens or formaldehyde releasers can result in skin irritation, hormonal imbalances and skin barrier damage, advises Dr Ameesha Mahajan.
The Delhi High Court has directed the GST Council to consider lowering or abolishing the goods and services tax on air purifiers, citing worsening air quality in the national capital. The court has asked the council to meet at the earliest, even via video conference if necessary, to address the issue.
Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.
An Enforcement Directorate (ED) probe has revealed that the manufacturer of Coldrif syrup, linked to the deaths of at least 20 children in Madhya Pradesh, used industrial-grade raw materials without quality checks. The investigation also found that Tamil Nadu Drugs Control Department officials were in frequent contact with the company but failed to conduct mandated inspections.
The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country
The Jan Vishwas (Amendment of Provisions) Bill 2025, aimed at decriminalizing minor offenses to promote ease of living and business, was introduced in the Lok Sabha and referred to a Select Committee.
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also referred to as 'cocktail' drugs.
The Delhi High Court has asked the central government why it cannot reduce the GST on air purifiers, considering the poor air quality in Delhi. The court's concern is that the current 18% GST makes air purifiers unaffordable for the common man.
Delhi's drugs control department has told the Delhi high court that it has launched prosecution against Gautam Gambhir Foundation and Aam Aadmi Party MLAs, Imran Hussain and Praveen Kumar, before a court for allegedly illegally stocking and distributing Covid drugs during the infection's second wave.
Samples of the powder for babies did not conform to standard pH value during a laboratory test, the regulator said.
The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.
The department also said there is nothing to suggest that the state authorities failed to address any shortage of COVID-19 drugs.
The show-cause notice dated February 8 by DCGI V G Somani cited a Delhi high court order dated December 12, 2018, which prohibits online sales of medicines without a licence.
ustice R Mahadevan passed the interim order on a plea moved by the Chennai-based Tamil Nadu Chemists & Druggists Association seeking a direction to authorities concerned to block the links of websites that selling medicines online.
Firms could lose licence if products not launched within 6 months of approval.
A day after the Supreme Court rapped the Health Ministry for allowing Indians to be used as 'guinea pigs' in the conduct of drug trials, top sources told PTI that the rules meant to monitor clinical trials under the Drugs and Cosmetics Act would be notified within this month.
Justice Rajiv Sahai Endlaw allowed 454 petitions moved by various pharma and healthcare majors, like Pfizer, Glenmark, Procter and Gamble and Cipla, challenging the government's March 10 notification banning the FDCs, saying the decision was taken by the Centre without following procedure prescribed in the Drugs and Cosmetics Act.
It has approved an amendment to the Drugs and Cosmetics Act.
Expanding the scope of its hearing in the Patanjali Ayurved case, the Supreme Court on Tuesday took a stern view of misleading advertisements by Fast-Moving Consumer Goods (FMCG) firms and asked three Union ministries to inform it about the steps they have taken to curb the practice which takes 'public for a ride' and adversely affects their health.
With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will be made compulsory for small and medium scale manufacturers in a phased manner. Union Health Minister Mansukh Mandaviya has asked micro-small and medium enterprises in pharma manufacturing to move towards good manufacturing practices (GMP) through self regulation. "This will help in quality assurance and also reduce compliance burden," Mandaviya.
The Delhi high court had earlier allowed Indian pharma major Wockhardt to sell its Ace Proxyvon tablets, which is a mixture of three salts -- aceclofenac, paracetamol and rabeprazol -- a combination that is banned.
